Actions of dopamine in canine subcutaneous adipose tissue.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D003891:Desipramine / Q000494:pharmacology; D004285:Dogs; D004298:Dopamine / Q000008:administration & dosage / Q000494:pharmacology*; D004336:Drug Antagonism; D004357:Drug Synergism; D005230:Fatty Acids, Nonesterified; D005260:Female; D005947:Glucose / Q000378:metabolism; D005990:Glycerol / Q000378:metabolism; D006859:Hydrogen / Q000378:metabolism; D007269:Injections, Intra-Arterial; D050356:Lipid Metabolism; D009638:Norepinephrine / Q000378:metabolism; D010477:Perfusion; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D012039:Regional Blood Flow; D014316:Tritium; D014655:Vascular Resistance / Q000187:drug effects
D005230:Fatty Acids, Nonesterified; D010643:Phenoxybenzamine; D014316:Tritium; D006859:Hydrogen; D005947:Glucose; D005990:Glycerol; D003891:Desipramine; D004298:Dopamine; D009638:Norepinephrine; D010646:Phentolamine